| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8674574 | Nutrition, Metabolism and Cardiovascular Diseases | 2018 | 7 Pages |
Abstract
Paricalcitol treatment for 12 weeks does not improve IR in patients with stage 3-4 CKD. Low vitamin D receptor activation is not a causal factor for IR in the CKD population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
B. Spoto, P. Pizzini, S. Cutrupi, G. Tripepi, G. Curatola, F. Mallamaci, C. Zoccali,